Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
5.42
-0.03 (-0.55%)
At close: Feb 11, 2026, 4:00 PM EST
5.43
0.00 (0.09%)
After-hours: Feb 11, 2026, 4:32 PM EST
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $317.51 million as of February 11, 2026. Its market cap has increased by 38.58% in one year.
Market Cap
317.51M
Enterprise Value
159.76M
1-Year Change
38.58%
Ranking
Category
Stock Price
$5.42
Market Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $317.51M, a decrease of -43.85%. That is a compound annual growth rate of -10.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 319.27M | 4.55% |
| Dec 31, 2025 | 305.38M | 16.38% |
| Dec 31, 2024 | 262.40M | -3.64% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protara Therapeutics | 345.10M |
| Puma Biotechnology | 333.09M |
| Aldeyra Therapeutics | 329.69M |
| Atea Pharmaceuticals | 325.01M |
| X4 Pharmaceuticals | 324.39M |
| Immuneering | 324.14M |
| Cybin | 319.88M |
| Candel Therapeutics | 316.21M |